MUMBAI, November 4, 2016 /PRNewswire/ --
Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.
(Photo: http://photos.prnewswire.com/prnh/20161104/436235 )
VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.
Diosmin/Hesperidin
Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.
More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/
Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.
Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.
About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com
Media Contact: Shantanu Singh [email protected] +91-22-26374592 Taj Pharmaceuticals Ltd.
Advertisement
Taj Pharma's VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures
Advertisement
Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.
(Photo: http://photos.prnewswire.com/prnh/20161104/436235 )
VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.
- Treatment of venous disease
- Chronic venous disease (CVD)
- Hemorrhoidal disease (HD)
- Dietary supplement
Diosmin/Hesperidin
Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.
More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/
Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.
Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.
About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com
Media Contact: Shantanu Singh [email protected] +91-22-26374592 Taj Pharmaceuticals Ltd.
